Advertisement

Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report

  • Masaya TaniwakiEmail author
  • Shinya Katsutani
  • Masahiro Yamasaki
  • Kazuma Kawamoto
  • Kunihiko Funaishi
  • Yu Matsumoto
  • Naoko Matsumoto
  • Nobuyuki Ohashi
  • Noboru Hattori
Letter to the Editor

Notes

Acknowledgements

We would like to thank Editage (www.editage.jp) for English language editing.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Ang AL, Kuperan P, Ng CH, Ng HJ (2009) Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost 101:852–859CrossRefGoogle Scholar
  2. 2.
    Kane WH, Davie EW (1988) Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71:539–555Google Scholar
  3. 3.
    Bayani N, Rugina M, Haddad-Vergnes L, Lelong F (2002) High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors. Am J Hematol 71:33–36CrossRefGoogle Scholar
  4. 4.
    Miesbach W, Voigt J, Peetz D, Scharrer I (2003) Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin. Med Klin (Munich) 98:339–343CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Respiratory DiseaseHiroshima Red Cross Hospital & Atomic-bomb Survivors HospitalHiroshimaJapan
  2. 2.Department of HematologyHiroshima Red Cross Hospital & Atomic-bomb Survivors HospitalHiroshimaJapan
  3. 3.Ohashi ClinicHiroshimaJapan
  4. 4.Department of Molecular and Internal Medicine, Institute of Biomedical & Health SciencesHiroshima UniversityHiroshimaJapan

Personalised recommendations